Eric Jen – Principal

Eric is an experienced CPA that assists clients to ensure compliance with federal and state regulations through aggregate spend system development and refinement, transparency reporting, compliance risk assurance, and monitoring and auditing.

Prior to founding COA, Eric consulted for dozens of pharmaceutical and medical device companies through OCS Biopartners and CIS by Deloitte, supporting clients through various compliance initiatives and working as an outsourced partner for their aggregate spend functions including system and policy development, spend monitoring and analytics, and government transparency reporting.  Eric has worked in-house in different Compliance roles, most recently as Director, Compliance for Heron Therapeutics. and Senior Manager, Transparency Reporting & Analytics for INSYS Therapeutics.  In-house, Eric led organizations’ compliance administration functions including transparency, auditing and monitoring, speaker programs, and spend analytics for internal decision-making and government investigations.  Prior to entering the life sciences industry, Eric served as an auditor at a national CPA firm.

Eric received his Bachelors of Science in Economics at the University of California, Berkeley. Eric holds a California Certified Public Accountant (CPA), Certification in Healthcare Compliance (CHC) from the Health Care Compliance Association, and a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professions Society.